本页面由Tiger Trade Technology Pte. Ltd.提供服务

Unicycive Therapeutics, Inc.

4.05
-0.0600-1.46%
盘后:4.110.0611+1.51%19:53 EDT
成交量:91.29万
成交额:368.79万
市值:1.13亿
市盈率:-2.60
高:4.11
开:4.10
低:3.99
收:4.11
52周最高:8.74
52周最低:3.93
股本:2,785.53万
流通股本:2,722.58万
量比:1.21
换手率:3.35%
股息:- -
股息率:- -
每股收益(TTM):-1.5585
每股收益(LYR):-1.6715
净资产收益率:-101.07%
总资产收益率:-40.59%
市净率:2.12
市盈率(LYR):-2.42

数据加载中...

2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/29

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/07/12

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/12

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/07

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/22

SEC问询函

CORRESP [Cover] - Correspondence